Analysis of allergic rhinitis by nano level and development of novel therapy
Analysis of allergic rhinitis by nano level and development of novel therapy
批准号:
17390458
负责人:
FUJIEDA Shigeharu
金额:
$10.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We proposed that fibroblasts are not passive players in the immune system. Incubation with poly(I:C) enhanced the secretion of RANTES and IL-8 from human nasal fibroblasts. However, eotaxin, IL-1β, TNF-α, IFNα, IFNγ and IL-12 were not secreted. The JNK inhibitor SP600125 and PI3-kinase inhibitor LY294002 significantly blocked the poly(I:C)-induced release RANTES and IL-8, whereas the p38 MAP kinase inhibitor SB203580 suppressed poly(I:C)-induced secretion of IL-8, but not RANTES. Eotaxin production by IL-4 is correlated with expression of SOCS5 in nasal fibroblast via PI3-kinase pathway. B lymphocyte stimulator protein (BLyS) was induced by poly(I:C). BLyS induced IgE class switching. Secretion of BLyS is associated with Rho, Syk, Vav, c-Src, TRAF6, p-Selectin.Plasmacytoid dendritic cells (pDC) produce a large amount of IFNα, through the ligation of TLR9 unmethylated CpG motifs. CpG DNA enhanced the NF-KB subunits p65/p50 activity, which collaborated with p38 MAPK to up-regulate the expression of IRF-7, CXCL10 and CCL3 in a manner independent of type I IFN signaling. Type I IFN induced the expression of IRF-7, but not of IFNα, in a NF-KB -independent way. CpG DNA enabled the type I IFN-treated pDC to express IFNα in the presence of NF-KB/p38 MAPK inhibitor, and chloroquine abrogated this effect. With CpG DNA, IRF-7, both constitutively and newly expressed, moved to the nuclei independent of NF-KB/p38 MAPK.Sublingeal immunotherapy (SLIT) was performed for seasonal allergic rhinitis in Japan. We found 8 proteins that increased in serum after SLIT. The amount of proteins is correlated with clinical outcome. Of 48,000 transcripts, 32-gene expression is increased in PBMC in patients received with SLIT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
シグナル伝達系に対するアレルギー性鼻炎の治療
信号转导系统治疗过敏性鼻炎
DOI:
--
发表时间:
2007
期刊:
アレルギーの臨床 27
影响因子:
--
作者:
[山田武千代, 高橋昇, 藤枝重治]
通讯作者:
藤枝重治
Roles of protein tyrosine kinese Syk in nasal polyps.
蛋白酪氨酸激酶 Syk 在鼻息肉中的作用。
DOI:
--
发表时间:
2005
期刊:
Clin Exp All Rev. 5
影响因子:
--
作者:
[Yamada T, Takahashi N, Sunaga H, Narita N, Yamamoto H., Fujieda S.]
通讯作者:
Fujieda S.
プロテオーム解析による花粉症関連たんぱく質の同定
通过蛋白质组分析鉴定花粉症相关蛋白质
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[牧野友香, 高橋昇, 大澤陽子, 小島章弘, 山田武千代, 目野浩二, 鈴木英昭, 内田和彦, 有波忠雄, 野口恵美子, 藤枝重治]
通讯作者:
藤枝重治
スギ花粉症に対する舌下免疫療法の有効性についての検討(平成19年度版)
舌下免疫疗法治疗雪松花粉病的有效性研究(2007年版)
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[高橋昇, 大澤陽子, 藤枝重治]
通讯作者:
藤枝重治
Vlgrl is required for proper stereocilia maturation of cochlear hair cells.
Vlgrl 是耳蜗毛细胞静纤毛适当成熟所必需的。
DOI:
--
发表时间:
2007
期刊:
Genes Cells 12
影响因子:
--
作者:
[Tanaka M, Teranishi T, Yoshimura Y, Tsutsumi T, Yagi H]
通讯作者:
Yagi H
共 15 条
Prevent and therapeutic strategy bycombination of microarray and proteomics for seasonal allergic rhinitis caused by Japanese cedar pollen.
-
批准号:23390397
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2011
-
负责人:FUJIEDA Shigeharu
-
依托单位:
New strategy for seasonal allergic rhinitis by exosomes
-
批准号:22659306
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.01万
-
财政年份:2010
-
负责人:FUJIEDA Shigeharu
-
依托单位:
The development of a new therapeutic moleculefor Japanese cedar pollinosis by proteomics analysis in the serum of patients treated with sublingual immunotherapy
-
批准号:20390441
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.65万
-
财政年份:2008
-
负责人:FUJIEDA Shigeharu
-
依托单位:
Establishment of gene therapy for the regulation of IgE and Chemokine production in patients with nasal allergy
-
批准号:13470359
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2001
-
负责人:FUJIEDA Shigeharu
-
依托单位:
Synthetic oligodeoxynucleotides inhibits IgE induction in human lymphocytes.
-
批准号:11671675
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:FUJIEDA Shigeharu
-
依托单位:
国内基金
去泛素化酶USP13稳定SOCS5调节自噬促进胶质母细胞瘤中的替莫唑胺耐药的机制研究
-
批准号:2026JJ80018
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡林旺
-
依托单位:
m6A修饰调控的miR-32-5p靶向Socs5促进巨噬细胞M1极化诱发UC
-
批准号:2023JJ30537
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:陈玲
-
依托单位:
miRNA-369-3p/SOCS5/mTOR轴调控肥大细胞自噬在MRSA肺炎中的作用及机制研究
-
批准号:82000005
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘超
-
依托单位: